OnCo
institutionsInstitution

Fred Hutchinson Cancer Center

Birthplace of bone marrow transplantation (Thomas, Nobel 1990) and a CAR-T pioneer (Riddell).

Transplant, CAR-T (Juno origins), HPV vaccine trials, SWOG statistical centre, Hutch Cancer Immunotherapy Integrated Research Center.

Location
Seattle, US
Type
cancer center · University of Washington
Newsweek 2026 oncology rank
Not in top 300 listing used
NCI designation
comprehensive
OnCo score
#133 · 31 points (0 Newsweek + 15 NCI + 16 from 8 linked objects) · ranking

Programmes

3top
  • Transplant
  • CAR-T
  • SWOG

People

9top
Denise A. Galloway
Director, Pathogen-Associated Malignancies Integrated Research Center, Fred Hutchinson Cancer Center
HPVViral oncologyCancer prevention

Virologist whose HPV research underpinned the vaccines that are eliminating cervical cancer.

Douglas S. Hawkins
Group Chair, Children's Oncology Group; Professor of Pediatrics, Seattle Children's and University of Washington
Paediatric sarcomaEwing sarcomaCooperative group trials

Paediatric oncologist who chairs the world's largest childhood cancer research organisation.

Gary H. Lyman
Professor, Public Health Sciences and Clinical Research Divisions, Fred Hutchinson Cancer Center
Supportive careHealth economicsComparative effectiveness

Gary Lyman is an oncologist and health economist behind guidelines on growth factors, thrombosis, and biosimilars in cancer care.

Hans-Peter Kiem
Director, Stem Cell and Gene Therapy Program, Fred Hutchinson Cancer Center
Gene therapyStem cell transplantationIn vivo gene editing

Hans-Peter Kiem is a gene and cell therapy researcher working on editing blood stem cells inside the body.

Michael LeBlanc
Group Statistician, SWOG Cancer Research Network; Member, Public Health Sciences Division, Fred Hutchinson Cancer Center
BiostatisticsClinical trial design

Michael LeBlanc is the statistician behind SWOG's trials, based at Fred Hutch's statistical centre.

Philip D. Greenberg
Head, Program in Immunology, Fred Hutchinson Cancer Center
T-cell immunotherapyTCR-TLeukaemia

Immunologist who spent four decades engineering T cells to attack leukaemia and solid tumours.

Sara A. Hurvitz
Senior Vice President and Director, Clinical Research Division, Fred Hutchinson Cancer Center; Head, Division of Hematology and Oncology, University of Washington
Breast cancerHER2ADCs

Sara Hurvitz is a breast cancer trialist who led DESTINY-Breast03, the trial where Enhertu beat Kadcyla.

Stanley R. Riddell
Professor, Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center
T-cell immunotherapyCAR-TAdoptive cell transfer

Adoptive T-cell therapy pioneer whose defined-composition CAR-T work led to lisocabtagene maraleucel.

Thomas J. Lynch Jr.
President and Director, Fred Hutchinson Cancer Center
Lung cancerTargeted therapyCancer center leadership

Thomas Lynch is a lung cancer oncologist who co-discovered EGFR mutations and now leads Fred Hutch.

Key papers

1top

Connected

17top